ACIU
Price
$2.10
Change
+$0.03 (+1.45%)
Updated
Jul 21, 03:39 PM (EDT)
Capitalization
208.24M
16 days until earnings call
NEUP
Price
$7.49
Change
+$0.04 (+0.54%)
Updated
Jul 21, 10:33 AM (EDT)
Capitalization
14.01M
Interact to see
Advertisement

ACIU vs NEUP

Header iconACIU vs NEUP Comparison
Open Charts ACIU vs NEUPBanner chart's image
AC Immune SA
Price$2.10
Change+$0.03 (+1.45%)
Volume$439
Capitalization208.24M
Neuphoria Therapeutics
Price$7.49
Change+$0.04 (+0.54%)
Volume$475
Capitalization14.01M
ACIU vs NEUP Comparison Chart in %
Loading...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACIU vs. NEUP commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a Hold and NEUP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (ACIU: $2.07 vs. NEUP: $7.45)
Brand notoriety: ACIU and NEUP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACIU: 116% vs. NEUP: 42%
Market capitalization -- ACIU: $208.24M vs. NEUP: $14.01M
ACIU [@Biotechnology] is valued at $208.24M. NEUP’s [@Biotechnology] market capitalization is $14.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whileNEUP’s FA Score has 1 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • NEUP’s FA Score: 1 green, 4 red.
According to our system of comparison, NEUP is a better buy in the long-term than ACIU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 3 TA indicator(s) are bullish while NEUP’s TA Score has 4 bullish TA indicator(s).

  • ACIU’s TA Score: 3 bullish, 3 bearish.
  • NEUP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ACIU and NEUP are a good buy in the short-term.

Price Growth

ACIU (@Biotechnology) experienced а -1.90% price change this week, while NEUP (@Biotechnology) price change was -3.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.79%. For the same industry, the average monthly price growth was +16.27%, and the average quarterly price growth was +35.62%.

Reported Earning Dates

ACIU is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+2.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACIU($208M) has a higher market cap than NEUP($14M). NEUP YTD gains are higher at: 117.201 vs. ACIU (-23.333). NEUP has higher annual earnings (EBITDA): 192K vs. ACIU (-49.71M). ACIU has more cash in the bank: 146M vs. NEUP (17M). NEUP has less debt than ACIU: NEUP (172K) vs ACIU (5.18M). ACIU has higher revenues than NEUP: ACIU (28.3M) vs NEUP (15.7M).
ACIUNEUPACIU / NEUP
Capitalization208M14M1,486%
EBITDA-49.71M192K-25,891%
Gain YTD-23.333117.201-20%
P/E RatioN/A0.40-
Revenue28.3M15.7M180%
Total Cash146M17M859%
Total Debt5.18M172K3,009%
FUNDAMENTALS RATINGS
ACIU: Fundamental Ratings
ACIU
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACIUNEUP
RSI
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
74%
Bullish Trend 8 days ago
89%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBVAF0.05N/A
N/A
Nubeva Technologies Ltd.
CRWE2.02N/A
N/A
Crown Equity Holdings, Inc.
FPRUY37.63N/A
N/A
Fraport AG
ATUSF19.96-0.08
-0.40%
Altius Minerals Corp.
VODPF1.06-0.01
-0.93%
Vodafone Group Plc

ACIU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with RGNX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
N/A
RGNX - ACIU
44%
Loosely correlated
-6.10%
ARCT - ACIU
44%
Loosely correlated
-0.30%
ABOS - ACIU
43%
Loosely correlated
+1.35%
RXRX - ACIU
41%
Loosely correlated
+5.80%
CRBU - ACIU
41%
Loosely correlated
+12.02%
More

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with QLGN. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then QLGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
-0.53%
QLGN - NEUP
61%
Loosely correlated
-7.67%
CMND - NEUP
31%
Poorly correlated
-0.99%
MNPR - NEUP
25%
Poorly correlated
-1.63%
PPBT - NEUP
25%
Poorly correlated
+2.77%
ACIU - NEUP
23%
Poorly correlated
N/A
More